Bionet Corp (訊聯生物科技), a leading cord blood bank company, said yesterday that it planned to launch a baby-tooth stem cell preservation service in July, with a forecast business opportunity of NT$9 billion (US$295.2 million), a company executive said.
The new preservation service will target the nation’s 2 million children aged between six and 12.
Preservation fees, which cost NT$150,000 over a 20-year period, could generate nearly NT$9 billion in business, based on Bionet’s forecast of a market penetration rate of 3 percent for its new service in the first stage, which will take at least two years.
“The new baby-tooth stem cell preservation service will help expand our service from pregnant women and newborn babies to the children’s market, with an estimated population of nearly 2 million,” Bionet chairman Chris Tsai (蔡政憲) told a media briefing.
The firm plans to cooperate with local dentists to promote the service, Tsai said.
Bionet said that teeth, as well as dental pulp and gums, are a rich source of stem cells. Once a child’s baby teeth fall out, they can become a source of stem cells after being processed and preserved by the company.
“Tooth stem cells are the third-generation stem cells after cord blood stem cells and mesenchymal stem cells (MSC),” Tsai said.
Bionet’s net profit surged 165.2 percent to NT$23.86 million last quarter from NT$9 million a year ago, the company’s latest report showed.
Speaking of industry challenges, Tsai said that Bionet and other local biotech firms were having difficulties obtaining government subsidies or tax breaks because of the administration’s narrow and outdated definition of biotechnology investments.
As a result, only three companies have sent in their applications so far, Tsai said.
Other challenges include potential industry consolidation or expansion in Asia and how that would impact on local biotech firms, he said.
Bionet’s gross margin rose to 78 percent last quarter from 75 percent a year ago, while its net earnings per share (EPS) surged 116.7 percent to NT$0.78 last quarter from NT$0.36 a year ago, the report showed.
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
STAYING AHEAD: TSMC expects its sales this year to grow 14 to 19 percent and could spend up to US$3.52 billion on research and development, leaving its rivals far behind Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) reported that the US last year approved 99 percent of its patent applications, which placed the tech giant among the top patent holders in the US. In its Corporate Social Responsibility Report, TSMC said it last year secured about 3,600 patents worldwide, including more than 2,300 in the US. As of the end of last year, TSMC owned more than 39,000 patents, the report said. The company last year filed almost 6,500 patent applications worldwide and ranked among the top 10 patent applicants in the US. In Taiwan, it was the largest patent applicant for the fourth